Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Yukinaga Nozawa"'
Autor:
Yuto Yamazaki, Yoshikiyo Ono, Fumitoshi Satoh, Yasuhiro Nakamura, Sadayoshi Ito, Kazue Ise, Yuta Tezuka, Yukinaga Nozawa, Scott A. Tomlins, Celso E. Gomez-Sanchez, William E. Rainey, Kei Omata, Ryo Morimoto, Hironobu Sasano
Publikováno v:
The Journal of clinical endocrinology and metabolism. 102(4)
Approximately half of patients with primary aldosteronism (PA) have clinically evident disease according to clinical (hypertension) and/or laboratory (aldosterone and renin levels) findings but do not have nodules detectable in routine cross-sectiona
Autor:
Yoshito Ohnuma, Toshiyuki Yano, Tetsuji Miura, Takayuki Miki, Yukinaga Nozawa, Kazuaki Shimamoto
Publikováno v:
Basic Research in Cardiology. 98:50-58
To obtain insight into the role of the mitochondrial ATP-sensitive K(+) (mitoK(ATP)) channel in ischemic preconditioning (PC), we aimed to clarify the mitoK(ATP) channel-dependent phase of PC in two PC protocols with different intervals between PC is
Autor:
Tetsuji Miura, Satoshi Genda, Tomoaki Matsumoto, Akihito Tsuchida, Masaya Tanno, Kazuaki Shimamoto, Yukinaga Nozawa, Atsushi Kuno, Takayuki Miki
Publikováno v:
Basic Research in Cardiology. 96:446-453
Objective The present study was designed to assess the relationship between the timing of a mitoKATP channel opener, diazoxide, and its infarct size-limiting effect. Methods In isolated rabbit hearts, infarction was induced by 30 min of global ischem
Autor:
Akihito Tsuchida, Kimio Nishizato, Masaya Hyakkoku, Yukinaga Nozawa, Tateki Asai, Kazufumi Tsuchihashi, Makoto Hagiwara, Kazuaki Shimamoto
Publikováno v:
Japanese Circulation Journal. 64:218-221
The use of the appetite suppressant agents aminorex and fenfluramine derivatives has been reported as a risk factor for the development of pulmonary hypertension. A 29-year-old female developed pulmonary hypertension suspected to be due to an ampheta
Autor:
Tetsuji Miura, Yukinaga Nozawa, Kazuaki Shimamoto, Akihito Tsuchida, Katsuo Suzuki, Takayuki Fukuma
Publikováno v:
Molecular and Cellular Biochemistry. 211:51-59
Both free radicals (FRs) and adenosine receptor activation contribute to triggering a mechanism of preconditioning (PC) against infarction. This study examined the possibility that there is some interaction between FRs and adenosine generation during
Autor:
Kazuaki Shimamoto, Hiroyuki Kita, Tetsuji Miura, Takayuki Fukuma, Yukinaga Nozawa, Akihito Tsuchida
Publikováno v:
Cardiovascular Drugs and Therapy. 13:151-157
Summary. This study examined whether chronic inhibition of the angiotensin-converting enzyme (ACE) lowers the threshold of preconditioning (PC) and potentiates cardioprotection of subthreshold PC. Rabbits were orally administered either 0.5 mg/kg/day
Autor:
Masaya Tanno, Tetsuji Miura, Kazuaki Shimamoto, Akihito Tsuchida, Hiroyuki Kita, Yukinaga Nozawa
Publikováno v:
Cardiovascular Drugs and Therapy. 12:365-373
The present study aimed to examine (1) whether the role of the opioid receptor in ischemic preconditioning (PC) is consistent regardless of the duration of ischemic insult and (2) which opioid receptor subtype contributes to PC. In the first series o
Autor:
Atsushi Doi, M T Yoko Hoshi, Yukinaga Nozawa, M T Masaya Sato, Satoshi Yuda, M T Takuya Sakasai, M T Harumi Katayama, Makoto Ogasawara, Hidemichi Kouzu, Tetsuji Miura, Takatoshi Nishimiya M.D., Masahiro Nishihara, M T Shoko Sato, M T Makoto Oka
Publikováno v:
Echocardiography (Mount Kisco, N.Y.). 31(2)
Background A considerable number of patients with atrial fibrillation (AF) develop cardioembolic stroke (CE) despite low CHADS2 score. We examined the possibility that use of the atrial electromechanical interval (AEMI) improves prediction of CE in p
Autor:
Yoshihiko Ichikawa, Tetsuji Miura, Nobuyuki Ura, Yukinaga Nozawa, Kazuaki Shimamoto, Atsushi Nakano, Takayuki Miki
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 366(4)
This study was designed to determine whether inhibition of neutral endopeptidase 24.11 (NEP) reduces infarct size and enhances protection afforded by ischemic preconditioning (PC) by elevation of the tissue bradykinin (BK) level in the heart in situ.